Bioprocessing White Papers
-
The Heroes Of Vaccine Development: Lipid Nanoparticles
2/8/2024
Lipid nanoparticles (LNPs) have played a crucial role in COVID-19 vaccine development as efficient mRNA delivery systems, exhibiting versatility and effectiveness in accelerating the process.
-
How To Make The Best LNPs
1/22/2024
There are various factors that require careful consideration throughout the process of formulating LNPs and utilizing them for successful mRNA delivery and translation.
-
Exploring The Future Of Viral Vector Development And Production
1/17/2024
The demand for viral vectors continues to grow, making addressing the challenges related to their manufacturing and scale-up increasingly critical.
-
Perspectives On The Adoption Of Fully Closed Processing
1/16/2024
In this study, industry experts share their perspectives and plans related to the implementation of fully closed processing. Explore the drivers and challenges of fully closed processing and more.
-
Potent Rifampicin Derivatives Can Clear MRSA Infections At Single Low Doses When Concomitantly Dosed With Vancomycin
1/4/2024
Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.
-
Cell Line Development: The Linchpin In Successful Biotherapeutic Development
1/4/2024
Review key factors for building a reliable CLD strategy and learn how the right CDMO can help you achieve the high quality, high yield, and speed needed to successfully bring a biologic to market.
-
The MAPPs Assay: A Useful Tool For The Assessment Of Immunogenicity
1/4/2024
Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.
-
Lowering The Lipids Barrier: The Key To Accelerating RNA-LNP Drug Development
12/27/2023
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
An Experienced CDMO Can Be A Differentiator In The Rapidly Growing Biologics Market
12/14/2023
Biotech and biopharma developers are increasingly relying on outsourcing partners to meet both clinical and commercial research, development, and production needs. CDMOs that provide end-to-end services, including secure supply chains, can help biologics developers meet accelerated timelines and establish a real competitive advantage in today’s competitive market.
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
12/12/2023
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.